Top Buy
| Security | Buy | Sell | Buy (1M) ▼ | Sell (1M) | Price | Target price | Potential |
|---|---|---|---|---|---|---|---|
| AbbVie Inc. | 31 | 0 | 9 | 0 | €171.58 | €180.22 | 5.035% |
| Insmed Inc. | 42 | 0 | 7 | 0 | €68.50 | €71.14 | 3.854% |
| Ionis Pharmaceuticals Inc. | 27 | 5 | 7 | 0 | €45.34 | €56.72 | 25.103% |
| Neurocrine Bioscience | 38 | 0 | 7 | 0 | €142.30 | €148.50 | 4.360% |
| Regeneron Pharmaceuticals Inc. | 47 | 1 | 6 | 0 | €992.80 | €1,046.4 | 5.394% |
| Eli Lilly Corp. | 62 | 1 | 6 | 1 | €729.60 | €824.47 | 13.002% |
| Vertex Pharmaceuticals Inc. | 57 | 2 | 5 | 0 | €452.50 | €440.93 | -2.557% |
| Johnson & Johnson | 41 | 1 | 5 | 0 | €148.40 | €179.00 | 20.620% |
| Medpace Holdings Inc | 16 | 0 | 5 | 0 | €339.80 | €418.12 | 23.050% |
| Biogen Inc. | 52 | 2 | 5 | 1 | €189.90 | €289.80 | 52.606% |
| Merck & Co. Inc. | 33 | 1 | 4 | 0 | €105.40 | €125.72 | 19.278% |
| Repligen Corp. | 17 | 0 | 4 | 0 | €143.15 | €178.01 | 24.353% |
| Arrowhead Pharmaceuticals Inc. | 21 | 2 | 4 | 0 | €24.31 | €54.98 | 126.166% |
| United Therapeutics | 25 | 1 | 4 | 1 | €293.10 | €290.24 | -0.976% |
| Exact Sciences | 17 | 0 | 3 | 0 | €48.40 | €75.89 | 56.800% |
| Exelixis Inc. | 20 | 0 | 3 | 0 | €21.84 | €26.01 | 19.077% |
| Natural Alternat. | 21 | 1 | 3 | 0 | €5.15 | - | - |